Eisai/Merck: doubling up, and down

Japanese group’s tie-up with US pharma on cancer drug will boost its research on Alzheimer’s

Original Article: Eisai/Merck: doubling up, and down

More From BioPortfolio on "Eisai/Merck: doubling up, and down"

• Related Companies
• Related Events
• Related Clinical Trials
• Related PubMed Entries
• Related Medications